India, Oct. 1 -- Humana Inc. (HUM), a healthcare company, on Thursday said it is expanding its Medicare Advantage offerings for 2027, with plans featuring affordable premiums, $0 cost-sharing on eligi... Read More
India, Oct. 1 -- Singer-songwriter and author Tori Amos has announced her second children's book, "A Sorta Fairytale," due out April 6, 2027, through Penguin Workshop, an imprint of Penguin Young Read... Read More
India, Oct. 1 -- Monte Rosa Therapeutics (GLUE) said it will present clinical results today, October 1, 2026 from the GFORCE-1 Phase 1 study of MRT-8102 in subjects with elevated cardiovascular diseas... Read More
India, Oct. 1 -- Synopsys, Inc. (SNPS) is up 9.38 percent, gaining $40.80 to $475.74 on Thursday. The move comes amid investor reaction to the company's strategic partnership with OpenAI to develop GP... Read More
India, Oct. 1 -- Thursday, Cyngn (CYN), an autonomous vehicle company, reported an increase in the Fleet Utilization by 45% quarter-over-quarter. Cyngn saw strong growth in vehicle use during the sec... Read More
India, Oct. 1 -- Heiwado Co. Ltd. (8276.T) revealed a profit for first half that Dropped, from the same period last year The company's bottom line came in at JPY3.580 billion, or JPY72.39 per share. ... Read More
India, Oct. 1 -- Thursday, Monte Rosa Therapeutics (GLUE) reported positive Phase 1 results for MRT-8102, showing broad reductions in inflammatory and cardiovascular disease-related biomarkers in obes... Read More
India, Oct. 1 -- United Therapeutics Corporation (UTHR) announced that the U.S. District Court for the District of Delaware ruled in its favor in patent litigation involving Liquidia Technologies' Yut... Read More
India, Oct. 1 -- Corteva, Inc. (CTVA) is down 84.29 percent, losing $65.45 to $12.20on Thursday. The move comes as the company advances its planned separation into two independent, publicly traded com... Read More
India, Sept. 30 -- Eli Lilly and Company (LLY) announced detailed results from the Phase 3 ACHIEVE-4 trial showing that Foundayo (orforglipron) demonstrated cardiovascular safety while delivering sust... Read More